Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 7 studies | 26% ± 18% |
Insufficient scRNA-seq data for expression of PI15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 5998.27 | 245 / 245 | 94% | 66.65 | 471 / 502 |
| breast | 84% | 6819.74 | 384 / 459 | 58% | 40.15 | 649 / 1118 |
| uterus | 100% | 3131.17 | 170 / 170 | 29% | 10.21 | 132 / 459 |
| lung | 64% | 724.54 | 370 / 578 | 60% | 4.93 | 688 / 1155 |
| intestine | 93% | 2265.13 | 900 / 966 | 28% | 2.42 | 149 / 527 |
| esophagus | 44% | 293.81 | 630 / 1445 | 72% | 9.20 | 132 / 183 |
| bladder | 81% | 709.00 | 17 / 21 | 32% | 1.72 | 160 / 504 |
| ovary | 93% | 1959.16 | 167 / 180 | 13% | 0.97 | 56 / 430 |
| adrenal gland | 50% | 319.79 | 128 / 258 | 37% | 1.79 | 85 / 230 |
| skin | 20% | 55.89 | 361 / 1809 | 62% | 29.50 | 294 / 472 |
| pancreas | 8% | 30.99 | 26 / 328 | 68% | 5.21 | 121 / 178 |
| spleen | 73% | 419.01 | 177 / 241 | 0% | 0 | 0 / 0 |
| stomach | 30% | 182.43 | 107 / 359 | 33% | 4.53 | 95 / 286 |
| blood vessel | 60% | 570.88 | 796 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 40% | 258.81 | 36 / 89 | 7% | 0.44 | 65 / 901 |
| brain | 31% | 132.78 | 806 / 2642 | 14% | 0.81 | 99 / 705 |
| thymus | 35% | 189.46 | 226 / 653 | 3% | 0.13 | 20 / 605 |
| heart | 36% | 305.15 | 310 / 861 | 0% | 0 | 0 / 0 |
| adipose | 33% | 297.75 | 401 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 31% | 6.04 | 9 / 29 |
| liver | 6% | 24.61 | 14 / 226 | 11% | 0.77 | 46 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 16% | 0.66 | 7 / 45 |
| muscle | 9% | 24.58 | 69 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.30 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008150 | Biological process | biological_process |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005615 | Cellular component | extracellular space |
| GO_0030414 | Molecular function | peptidase inhibitor activity |
| Gene name | PI15 |
| Protein name | Peptidase inhibitor 15 (PI-15) (25 kDa trypsin inhibitor) (p25TI) (Cysteine-rich secretory protein 8) (CRISP-8) (SugarCrisp) |
| Synonyms | P25TI CRISP8 |
| Description | FUNCTION: Serine protease inhibitor which displays weak inhibitory activity against trypsin . May play a role in facial patterning during embryonic development (By similarity). . |
| Accessions | ENST00000523773.1 ENST00000260113.7 ENST00000649643.1 O43692 |